Lunai Bioworks Inc.
LNAI
$1.25
-$0.01-0.79%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -54.53% | -19.96% | -44.79% | 20.37% | -36.05% |
| Depreciation & Amortization | 28.09% | 4.82% | 5.61% | -3.31% | 18.68% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -56.74% | -24.71% | -52.54% | 6.47% | -35.57% |
| Operating Income | 56.74% | 24.71% | 52.54% | -6.47% | 35.57% |
| Income Before Tax | 106.38% | -705.59% | 100.32% | -60.13% | -381.87% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 106.38% | -705.59% | 100.32% | -60.13% | -381.87% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 106.38% | -705.59% | 100.32% | -60.13% | -381.87% |
| EBIT | 56.74% | 24.71% | 52.54% | -6.47% | 35.57% |
| EBITDA | 57.22% | 24.88% | 52.74% | -6.54% | 35.74% |
| EPS Basic | 104.53% | -589.73% | 100.22% | 34.84% | -94.21% |
| Normalized Basic EPS | 68.83% | 48.57% | 67.79% | 58.11% | 73.98% |
| EPS Diluted | 104.53% | -584.62% | 100.21% | 34.84% | -94.21% |
| Normalized Diluted EPS | 68.83% | 48.57% | 68.10% | 58.11% | 73.98% |
| Average Basic Shares Outstanding | 40.76% | 16.80% | 48.59% | 145.74% | 148.12% |
| Average Diluted Shares Outstanding | 40.76% | 16.80% | 50.05% | 145.74% | 148.12% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |